Axogen Analyst Ratings
Axogen Analyst Ratings
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a initiated with a price target of $0.00 to $9.00. The current price Axogen (AXGN) is trading at is $4.01, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | 124.44% | Leerink Partners | → $9 | Initiates Coverage On | → Outperform |
| 09/26/2023 | 299% | Cantor Fitzgerald | → $16 | Reiterates | Overweight → Overweight |
| 08/22/2023 | 299% | Cantor Fitzgerald | → $16 | Reiterates | Overweight → Overweight |
| 05/10/2023 | 398.75% | JMP Securities | → $20 | Reiterates | → Market Outperform |
| 03/28/2023 | 274.06% | Canaccord Genuity | → $15 | Reiterates | → Buy |
| 03/15/2023 | 398.75% | JMP Securities | → $20 | Reiterates | → Market Outperform |
| 11/11/2022 | 274.06% | Jefferies | → $15 | Assumes | → Buy |
| 05/09/2022 | 274.06% | Canaccord Genuity | $10 → $15 | Upgrades | Hold → Buy |
| 05/05/2022 | 249.13% | SVB Leerink | $12 → $14 | Maintains | Outperform |
| 11/04/2021 | 398.75% | JMP Securities | $25 → $20 | Maintains | Market Outperform |
| 05/06/2021 | 498.5% | Canaccord Genuity | $21 → $24 | Maintains | Hold |
| 02/23/2021 | 423.69% | Canaccord Genuity | $20 → $21 | Maintains | Hold |
| 02/23/2021 | 573.32% | SVB Leerink | $23 → $27 | Maintains | Outperform |
| 10/23/2020 | 498.5% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
| 08/06/2020 | 286.53% | SVB Leerink | $13.5 → $15.5 | Maintains | Outperform |
| 05/07/2020 | 199.25% | Canaccord Genuity | → $12 | Downgrades | Buy → Hold |
| 04/02/2020 | — | BTIG | Downgrades | Buy → Neutral | |
| 11/07/2019 | 523.44% | Canaccord Genuity | $30 → $25 | Maintains | Buy |
| 11/07/2019 | 373.82% | Cantor Fitzgerald | $21 → $19 | Maintains | Overweight |
| 08/07/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 03/25/2019 | 598.25% | BTIG | → $28 | Upgrades | Neutral → Buy |
| 11/14/2018 | — | BTIG | Initiates Coverage On | → Neutral | |
| 10/30/2018 | 972.32% | Cantor Fitzgerald | $45 → $43 | Maintains | Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/16/2023 | 124.44% | Leerink合作伙伴 | →$9 | 开始承保 | →跑赢大盘 |
| 09/26/2023 | 299% | 康托·菲茨杰拉德 | →$16 | 重申 | 超重→超重 |
| 2023年08月22日 | 299% | 康托·菲茨杰拉德 | →$16 | 重申 | 超重→超重 |
| 2023年05月10日 | 398.75% | JMP证券 | →$20 | 重申 | →市场跑赢大盘 |
| 03/28/2023 | 274.06% | 卡纳科特·格纳奇 | →$15 | 重申 | →购买 |
| 03/15/2023 | 398.75% | JMP证券 | →$20 | 重申 | →市场跑赢大盘 |
| 2022年11月11日 | 274.06% | 杰富瑞 | →$15 | 假设 | →购买 |
| 05/09/2022 | 274.06% | 卡纳科特·格纳奇 | $10→$15 | 升级 | 持有→购买 |
| 05/05/2022 | 249.13% | SVB Leerink | $12→$14 | 维护 | 跑赢大盘 |
| 11/04/2021 | 398.75% | JMP证券 | $25→$20 | 维护 | 市场表现强于大盘 |
| 05/06/2021 | 498.5% | 卡纳科特·格纳奇 | $21→$24 | 维护 | 保持 |
| 02/23/2021 | 423.69% | 卡纳科特·格纳奇 | $20→$21 | 维护 | 保持 |
| 02/23/2021 | 573.32% | SVB Leerink | $23→$27 | 维护 | 跑赢大盘 |
| 10/23/2020 | 498.5% | 古根海姆 | →$24 | 开始承保 | →购买 |
| 08/06/2020 | 286.53% | SVB Leerink | $13.5→$15.5 | 维护 | 跑赢大盘 |
| 05/07/2020 | 199.25% | 卡纳科特·格纳奇 | →$12 | 评级下调 | 购买→Hold |
| 04/02/2020 | - | BTIG | 评级下调 | 购买→中性 | |
| 2019/07/11 | 523.44% | 卡纳科特·格纳奇 | $30→$25 | 维护 | 买 |
| 2019/07/11 | 373.82% | 康托·菲茨杰拉德 | $21→$19 | 维护 | 超重 |
| 2019年08月07日 | - | 威廉·布莱尔 | 评级下调 | 跑赢→市场表现 | |
| 2019年03月25日 | 598.25% | BTIG | →$28 | 升级 | 中性→购买 |
| 2018年11月14日 | - | BTIG | 开始承保 | →中性 | |
| 2018年10月30日 | 972.32% | 康托·菲茨杰拉德 | $45→$43 | 维护 | 超重 |
What is the target price for Axogen (AXGN)?
AXGN的目标价是多少？
The latest price target for Axogen (NASDAQ: AXGN) was reported by Leerink Partners on October 16, 2023. The analyst firm set a price target for $9.00 expecting AXGN to rise to within 12 months (a possible 124.44% upside). 7 analyst firms have reported ratings in the last year.
Leerink Partners于2023年10月16日报道了阿克苏根(纳斯达克代码：AXGN)的最新目标价。这家分析公司将目标价定为9美元，预计AXGN将在12个月内升至(可能上涨124.44)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Axogen (AXGN)?
安盛(AXGN)的最新分析师评级是多少？
The latest analyst rating for Axogen (NASDAQ: AXGN) was provided by Leerink Partners, and Axogen initiated their outperform rating.
纳斯达克(Sequoia Capital：AXGN)的最新分析师评级由Leerink Partners提供，Axogen启动了其表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for Axogen (AXGN)?
Axogen(AXGN)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Axogen的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Axogen的上一次评级是在2023年10月16日提交的，因此您应该预计下一次评级将在2024年10月16日左右提供。
Is the Analyst Rating Axogen (AXGN) correct?
分析师评级Axogen(AXGN)正确吗？
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a initiated with a price target of $0.00 to $9.00. The current price Axogen (AXGN) is trading at is $4.01, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Axogen(AXGN)评级是以0.00美元至9.00美元的目标价启动的。Axogen(AXGN)目前的交易价格为4.01美元，在分析师的预测范围内。